Literature DB >> 17054417

Monitoring the health to disease continuum with global metabolic profiling and systems biology.

Laura K Schnackenberg1, Richard D Beger.   

Abstract

Global metabolic profiling, which includes both metabolomics and metabonomics studies, is the latest 'omics' research platform that is being applied to understand the health and disease continuum. Metabolic profiling analyses have been demonstrated for the investigation of inborn errors of metabolism, organ transplant rejection, drug toxicity, disease diagnosis and prognosis, drug efficacy and nutritional status. Combining information generated from a metabolic profiling platform with that obtained based on genetics, transcriptomics and proteomics research paradigms will pave the way for a better understanding of the mechanisms of disease and toxicity. Metabolomics and nutrition will lay the groundwork for the application of personalized medicine in the 21st century.

Entities:  

Mesh:

Year:  2006        PMID: 17054417     DOI: 10.2217/14622416.7.7.1077

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  18 in total

1.  Individual variation in macronutrient regulation measured by proton magnetic resonance spectroscopy of human plasma.

Authors:  Youngja Park; Seoung Bum Kim; Bing Wang; Roberto A Blanco; Ngoc-Anh Le; Shaoxiong Wu; Carolyn J Accardi; R Wayne Alexander; Thomas R Ziegler; Dean P Jones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-20       Impact factor: 3.619

Review 2.  Postgenomics diagnostics: metabolomics approaches to human blood profiling.

Authors:  Oxana Trifonova; Petr Lokhov; Alexander Archakov
Journal:  OMICS       Date:  2013-09-17

Review 3.  Metabolomics in pediatric nephrology: emerging concepts.

Authors:  Mina H Hanna; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2014-07-17       Impact factor: 3.714

4.  Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.

Authors:  Kajsa Kajander; Eveliina Myllyluoma; Sinikka Kyrönpalo; Martin Rasmussen; Pentti Sipponen; Ismo Mattila; Tuulikki Seppänen-Laakso; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

Review 5.  A niche for infectious disease in environmental health: rethinking the toxicological paradigm.

Authors:  Beth J Feingold; Leora Vegosen; Meghan Davis; Jessica Leibler; Amy Peterson; Ellen K Silbergeld
Journal:  Environ Health Perspect       Date:  2010-04-12       Impact factor: 9.031

6.  Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.

Authors:  Diana R Wetmore; Elizabeth Joseloff; Joseph Pilewski; Douglas P Lee; Kay A Lawton; Matthew W Mitchell; Michael V Milburn; John A Ryals; Lining Guo
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

7.  Organization of GC/MS and LC/MS metabolomics data into chemical libraries.

Authors:  Corey D Dehaven; Anne M Evans; Hongping Dai; Kay A Lawton
Journal:  J Cheminform       Date:  2010-10-18       Impact factor: 5.514

8.  Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction.

Authors:  Taru-K Pilvi; Tuulikki Seppanen-Laakso; Helena Simolin; Piet Finckenberg; Anne Huotari; Karl-Heinz Herzig; Riitta Korpela; Matej Oresic; Eero-M Mervaala
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

9.  Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue.

Authors:  Gang Sun; Kui Yang; Zhongdan Zhao; Shaoping Guan; Xianlin Han; Richard W Gross
Journal:  Anal Chem       Date:  2007-08-01       Impact factor: 6.986

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.